Wird geladen...
Phase I/II Clinical Trial of Hyaluronan-Cisplatin Nanoconjugate for the Treatment of Spontaneous Canine Cancers
OBJECTIVE: To conduct an open label, multi-dose Phase I/II clinical study in spontaneous canine cancers and evaluate the pharmacokinetics, safety, and efficacy of the hyaluronan-based cisplatin formulation (HA-Pt). ANIMALS: 13 dogs with heterogeneous, naturally occurring cancers. PROCEDURES: The dog...
Gespeichert in:
| Veröffentlicht in: | Am J Vet Res |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5008241/ https://ncbi.nlm.nih.gov/pubmed/27580113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2460/ajvr.77.9.1005 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|